The diaryl oxazole PC-046 is a tubulin-binding agent with experimental anti-tumor efficacy in hematologic cancers

Author： Landowski Terry   Samulitis Betty   Dorr Robert  

Publisher： Springer Publishing Company

ISSN： 0167-6997

Source： Investigational New Drugs, Vol.31, Iss.6, 2013-12, pp. : 1616-1625

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Factors affecting solubilization of a poorly soluble novel tubulin-binding agent

By Shah Amit K.   Wyandt Christy M.  

Pharmaceutical Development and Technology, Vol. 18, Iss. 6, 2013-12 ,pp. : 1319-1328

Informa Healthcare

Access to resources Recommend Favorite

Mechanisms of action and resistance to tubulin-binding agents

By Dumontet C.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 4, 2000-04 ,pp. : 779-788

Informa Healthcare

Access to resources Recommend Favorite

The effects of tubulin-binding agents on stretch-induced ventricular arrhythmias

By Parker K.K.   Taylor L.K.   Atkinson B.   Hansen D.E.   Wikswo J.P.  

European Journal of Pharmacology, Vol. 417, Iss. 1, 2001-04 ,pp. : 131-140

Elsevier

Access to resources Recommend Favorite

Small-molecule, tubulin-binding compounds as vascular targeting agents

By Marx Matthew A  

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 6, 2002-06 ,pp. : 769-776

Informa Healthcare

Access to resources Recommend Favorite

Improving the Targeting of Tubulin-Binding Agents: Lessons from Drug Resistance Studies

By  

Current Pharmaceutical Design, Vol. 11, Iss. 13, 2005-05 ,pp. : 1719-1733

Bentham Science Publishers

Access to resources Recommend Favorite